Efficacy of Spleen Aminopeptide Combined with Pidotimod in Adjuvant Treatment of Children with Asthma and Its Effects on Expression of Interferon Regulatory Factor 1 and Signal Transducer and Activator of Transcription-1

Wang Gangzuo; Xu Jiangwei

doi:10.13407/j.cnki.jpp.1672-108X.2022.09.012

您当前的位置：

首页 >

文章列表页 >

Efficacy of Spleen Aminopeptide Combined with Pidotimod in Adjuvant Treatment of Children with Asthma and Its Effects on Expression of Interferon Regulatory Factor 1 and Signal Transducer and Activator of Transcription-1

更新时间：2022-11-04

- Efficacy of Spleen Aminopeptide Combined with Pidotimod in Adjuvant Treatment of Children with Asthma and Its Effects on Expression of Interferon Regulatory Factor 1 and Signal Transducer and Activator of Transcription-1
- Vol. 28, Issue 9, Pages: 44-47(2022)
- 作者机构：
  
  恩施土家族苗族自治州中心医院,湖北,恩施,445000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2022.09.012
  CLC：
- Published：2022，
扫描看全文
Wang Gangzuo, Xu Jiangwei. Efficacy of Spleen Aminopeptide Combined with Pidotimod in Adjuvant Treatment of Children with Asthma and Its Effects on Expression of Interferon Regulatory Factor 1 and Signal Transducer and Activator of Transcription-1. [J]. 28(9):44-47(2022)
DOI：

Wang Gangzuo, Xu Jiangwei. Efficacy of Spleen Aminopeptide Combined with Pidotimod in Adjuvant Treatment of Children with Asthma and Its Effects on Expression of Interferon Regulatory Factor 1 and Signal Transducer and Activator of Transcription-1. [J]. 28(9):44-47(2022) DOI： 10.13407/j.cnki.jpp.1672-108X.2022.09.012.

摘要

目的：探讨脾氨肽联合匹多莫德辅助治疗儿童哮喘的效果与机制。方法：选取2020年3月至2021年3月我院儿科诊治的支气管哮喘急性发作期患儿178例，按随机数表法分为观察组和对照组各89例。两组均采用常规治疗与管理，观察组在此基础上加用脾氨肽和匹多莫德，比较两组疗效，检测治疗前后的T淋巴细胞亚群CD3+、CD4+、CD8+、CD4+/CD8+水平，记录症状（咳喘、呼吸困难、哮鸣音）消失时间，采用2-ΔΔCt相对定量法分析治疗前后外周血干扰素调控因子1（IRF1）和信号转导转录活化因子-1（STAT1）的相对表达量。结果：观察组总有效率92.13%，高于对照组的75.28%（P<0.01）；观察组咳喘消失时间、呼吸困难消失时间、哮鸣音消失时间均短于对照组（P均<0.01）。两组患儿治疗后CD3+、CD4+、CD4+/CD8+均高于治疗前，CD8+、IRF1、STAT1均低于治疗前，且观察组治疗后CD3+、CD4+、CD4+/CD8+均高于对照组，CD8+、IRF1、STAT1均低于对照组（P均<0.05）。结论：在常规治疗与管理基础上加用脾氨肽和匹多莫德，可改善哮喘患儿的免疫功能，缩短症状消失时间，抑制IRF1、STAT1的表达，从而有效提高治疗效果。

Abstract

Objective: To probe into the effect and mechanism of spleen aminopeptide combined with pidotimod in the adjuvant treatment of children with asthma. Methods: Totally 178 children with acute attack of bronchial asthma admitted into pediatrics of our hospital from Mar. 2020 to Mar. 2021 were extracted to be divided into the observation group and the control group via the random number table

with 89 cases in each group. Both groups were treated with conventional treatment and management

and the observation group was additionally given spleen aminopeptide combined with pidotimod. The efficacy of two groups was compared

and the levels of CD3+

CD4+

CD8+ and CD4+/CD8+ of T lymphocyte subsets before and after treatment were detected. The disappearance time of clinical symptoms (cough and asthma

dyspnea and wheezing) was recorded. Relative expression levels of interferon regulator factor 1 (IRF1) and signal transducer and activator of transcription-1 (STAT1) in peripheral blood before and after treatment were analyzed by 2-ΔΔCt relative quantification method. Results: The total effective rate in the observation group was 92.13%

higher than 75.28% in the control group (P<0.05). The disappearance time of cough and asthma

dyspnea and wheezing in the observation group were shorter than those in the control group (P<0.01). After treatment

the levels of CD3+

CD4+

CD4+/CD8+ in two groups were higher than those before treatment

the levels of CD8+

IRF1

STAT1 were lower than those before treatment

and the levels of CD3+

CD4+

CD4+/CD8+ in the observation group were higher than those in the control group after treatment

the levels of CD8+

IRF1 and STAT1 were lower than those in the control group (P<0.05). Conclusion: On the basis of routine treatment and management

spleen aminopeptide combined with pidotimod can improve the immune function of children with asthma

shorten the disappearance time of symptoms

inhibit the expression of IRF1 and STAT1

so as to effectively improve the therapeutic effect.

关键词

脾氨肽匹多莫德哮喘儿童干扰素调控因子1信号转导转录活化因子-1

Keywords

spleen aminopeptidepidomodeasthmachildrennterferon regulatory factor 1signal transducer and activator of transcription-1

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta-Analysis of Influencing Factors of Treatment Compliance in Children with Asthma in China

Comprehensive Evaluation of Inhaled Corticosteroids Suspensionin Children with Acute Asthma

Effects of Huaiqihuang granules on Small Airway Function and Immune Function in Children with Mild Persistent Asthma

Investigation of Antimicrobial Use in Parents of Children with Asthma in Qingdao Area

Characteristics of Sleep-Disordered Breathing in Children with Bronchial Asthma

Related Author

Luo Nan

Wang Ling

Yuan Xiaoping

郭蓉

Yu Yuncui

Wang Shu

He Xiaojing

Xiang Li

Related Institution

Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics

National Center for Children’s Health, China, Beijing Children’s Hospital, Capital Medical University

Shengjing Hospital of China Medical University

Affiliated Hospital of Xuzhou Medical University, Jiangsu Xuzhou

Qingdao Huangdao District Central Hospital, ShandongQingdao

⁰